This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_LIPORALPHARYNX_EXALLC for full statistics.
Carcinoma in situ of lip, oral cavity and pharynx
CD2_INSITU_LIPORALPHARYNX
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
87 |
4. Check minimum number of eventsNone |
87 |
5. Include endpointsNone |
87 |
6. Filter based on genotype QC (FinnGen only) |
87 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00
- Name in latin
- Carcinoma in situ labii (oris)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of lip, oral cavity and pharynx
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of lip, oral cavity and pharynx
- Carcinoma in situ of oral cavity, oesophagus and stomach
- Carcinoma in situ of oral cavity, oesophagus and stomach
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 87 | 29 | 58 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 67.18 | 69.00 | 66.26 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 73
- Matched controls
- 729
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
49.2
22.1
26
8
D00.00
ICD-10 Finland
Cancer in situ on the lip red border
+∞
18.5
17
*
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
14.0
13
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
25.9
13.3
18
9
D00.09
ICD-10 Finland
Unspecified cancer in situ in oral cavity and throat
+∞
12.9
12
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
155.7
12.9
13
*
SBA00
NOMESCO Finland
Microbiological examinations
155.7
12.9
13
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
77.8
12.0
13
*
EKA10
NOMESCO Finland
Biopsy of cheek
23.1
10.8
15
8
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
10.7
10
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
+∞
10.7
10
*
TEA00
NOMESCO Finland
Biopsy of lip
63.8
9.9
11
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.4
9.9
17
16
D00.04
ICD-10 Finland
In situ cancer of the floor of the mouth
+∞
9.6
9
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
57.1
8.9
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.7
8.8
39
143
K13.78
ICD-10 Finland
Other change in the oral mucosa
23.5
8.8
12
6
ECA20
NOMESCO Finland
Biopsy of gingiva
31.8
8.8
11
*
SAA03
NOMESCO Finland
Extended examination of mouth
4.5
8.5
40
154
EAA10
NOMESCO Finland
Excision of lesion of lip
50.6
7.9
9
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
21.2
7.9
11
6
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
7.4
7
*
D00.01
ICD-10 Finland
In situ cancer of the mucous membrane of the cheek
+∞
7.4
7
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
19.0
7.0
10
6
A07AA02
ATC
nystatin; oral
7.6
7.0
16
26
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
14.1
6.8
11
9
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
76.2
6.5
7
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
76.2
6.5
7
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
29.5
6.4
8
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
6.3
6
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
6.3
6
*
D00.05
ICD-10 Finland
In situ cancer of the pharyngeal part of the tongue
+∞
6.3
6
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
6.3
6
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.0
6.1
20
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
26
62
5.55
11.01
2.8
2.4
g/l
0.2
0.2
0.13
26
53
(3026389) Candida sp identified in Specimen by Organism specific culture
10
7
15.90
6.57
3.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
45
245
2.73
5.04
4.0
2.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
19
64
3.52
4.92
1.3
1.3
titre
368.0
272.7
—
5
11
(3002256) Pathology report gross observation
21
78
3.23
4.66
1.8
1.3
—
—
—
0
0
(4035726)
19
67
3.35
4.57
1.6
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
49
291
2.57
4.45
5.6
4.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
83
3.02
4.18
1.9
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
30
146
2.61
4.05
3.3
2.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
50
310
2.44
4.00
7.3
6.0
e9/l
0.6
0.6
0.08
41
264
(3006315) Basophils [#/volume] in Blood
50
312
2.42
3.92
7.3
6.0
e9/l
0.0
0.0
0.08
41
267
(3000991) Gas panel - Venous blood
16
57
3.21
3.76
6.4
10.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
244
0.30
3.74
3.4
3.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
50
318
2.35
3.68
7.3
6.1
e9/l
1.8
1.8
0.07
43
276
(3013115) Eosinophils [#/volume] in Blood
50
321
2.31
3.56
7.4
6.1
e9/l
0.2
0.2
1.13
43
274
(3003396) Base excess in Arterial blood by calculation
21
92
2.69
3.44
6.9
8.2
mmol/l
0.5
1.6
0.71
16
71
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
55
3.09
3.35
2.1
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
24
114
2.53
3.34
2.4
2.5
e6/l
0.3
0.8
1.60
18
67
(3018677) aPTT in Platelet poor plasma by Coagulation assay
23
109
2.51
3.21
1.6
1.8
s
28.5
29.4
0.52
23
103
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
44
277
2.19
3.19
2.2
2.0
pmol/l
86.0
92.8
0.48
24
139
(3044640) Blood type and Crossmatch panel - Blood
35
202
2.23
3.13
3.7
2.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
40
3.32
3.11
2.3
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
8
7.95
3.10
1.5
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
40
248
2.13
2.96
2.2
2.4
nmol/l
77.4
75.2
0.20
35
213
(3042936) Bacteria identified in Isolate by Culture
23
113
2.41
2.96
2.9
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
122
2.34
2.86
2.8
1.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
44
287
2.08
2.82
6.5
6.0
%
59.9
59.3
0.11
39
266
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
17
76
2.54
2.65
3.2
2.8
umol/l
19.5
8.8
0.37
17
63
(3002030) Lymphocytes/100 leukocytes in Blood
44
292
2.03
2.64
6.7
6.3
%
24.2
25.9
0.46
39
269
(3023368) Bacteria identified in Blood by Culture
36
223
2.05
2.61
7.6
4.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
85
2.41
2.50
2.3
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
13
4.87
2.31
1.3
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
33
207
1.96
2.25
6.5
5.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
32
200
1.95
2.20
3.6
3.1
e6/l
0.4
0.5
0.13
26
149
(36304419) Bacteria [Presence] in Urine
31
195
1.92
2.08
3.6
3.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
33
2.92
2.00
1.3
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
25
148
1.97
1.98
1.3
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
26
157
1.94
1.95
10.0
6.3
—
—
—
0
0
(3012544) pH of Venous blood
14
66
2.34
1.94
5.1
4.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
40
2.69
1.91
9.5
7.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
17
3.71
1.87
1.8
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
89
2.13
1.86
2.1
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
50
377
1.77
1.80
13.3
10.0
e9/l
4.4
4.4
0.01
45
323
(3017143) Hepatitis C virus Ab [Presence] in Serum
14
70
2.19
1.70
1.2
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
13
63
2.25
1.70
5.4
4.2
mmol/l
1.7
2.9
0.44
13
50
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
32
2.65
1.64
4.1
2.8
%
0.7
0.6
—
8
32
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
57
2.28
1.64
1.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
20
3.14
1.61
1.8
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
33
2.56
1.58
4.1
2.9
%
2.0
1.2
—
8
33
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
37
264
1.70
1.57
4.0
3.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
15
3.47
1.54
5.4
4.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
21
2.99
1.53
1.8
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
35
248
1.69
1.51
3.8
3.8
e6/l
71.7
88.5
0.11
26
185
(3022621) pH of Urine by Test strip
9
38
2.52
1.51
2.2
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
75
655
2.05
1.50
31.5
16.3
mg/l
40.8
25.0
1.95
62
532
(3002582) Erythrocytes [#/volume] in Urine
32
222
1.70
1.49
3.9
3.2
e6/l
68.9
309.2
0.40
27
174
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
22
2.85
1.46
4.5
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
16
3.25
1.46
1.6
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
90
1.95
1.45
1.4
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
61
2.12
1.40
1.4
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
23
2.72
1.39
3.5
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
18
108
1.84
1.35
2.8
2.6
e6/l
1.5
2.3
0.36
12
62
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
15
85
1.92
1.33
4.9
4.0
u/l
218.8
263.1
1.17
15
77
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
6
24
2.61
1.33
4.8
3.3
mg/l
21.7
36.5
—
6
19
(3019309) Folate [Moles/volume] in Red Blood Cells
21
134
1.75
1.30
1.4
1.7
nmol/l
1205.2
1361.0
0.31
16
100
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
16
94
1.86
1.28
10.9
10.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
36
2.34
1.28
1.3
2.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
11
191
0.51
1.23
3.5
3.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.73
1.23
1.0
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
28
200
1.59
1.13
4.1
3.3
mg/l
35.5
376.2
0.57
22
133
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
17
106
1.75
1.13
2.6
2.3
%
15.8
21.9
1.26
12
94
(3022313) Gas panel - Capillary blood
7
32
2.29
1.11
6.7
3.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
32
2.29
1.11
3.6
4.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
9
45
2.11
1.09
6.2
3.1
g/l
129.6
129.4
—
9
45
(3032080) INR in Blood by Coagulation assay
40
316
1.49
1.01
7.7
10.6
inr
1.0
1.3
—
6
101
(3026008) Bacteria identified in Urine by Culture
28
205
1.54
1.01
4.0
3.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
7
36
2.03
0.99
7.7
2.8
mmol/l
26.7
24.8
—
7
36
(3036481) Cortisol [Moles/volume] in Serum or Plasma
11
62
1.89
0.99
2.1
2.6
nmol/l
334.0
338.3
0.02
11
53
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
78
1.78
0.98
1.2
1.5
—
—
—
0
0
(4010399)
10
55
1.92
0.96
1.5
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
52
1.81
0.96
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
28
2.22
0.93
3.0
2.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
43
351
1.45
0.90
2.9
2.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
30
2.07
0.89
1.0
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
8
46
1.81
0.85
6.6
3.1
—
7.5
—
0
6
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
46
1.81
0.85
8.0
7.1
mmol/l
23.6
25.4
—
8
46
(3021589) Normoblasts [#/volume] in Blood
37
297
1.43
0.83
9.4
11.6
e9/l
0.0
0.0
0.79
29
253
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
33
1.88
0.80
1.2
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
5
23
2.24
0.77
2.8
1.7
u/ml
0.2
0.3
—
5
8
(3045414) Leukocytes [Presence] in Urine
5
24
2.15
0.76
2.4
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
28
217
1.43
0.75
4.5
4.0
mg/mmol
4.0
11.5
1.34
22
138
(3022145) Colonoscopy Study observation
11
71
1.63
0.66
1.4
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
29
1.77
0.65
1.6
1.2
u/ml
101.0
148.3
—
5
24
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
30
1.71
0.62
12.2
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
50
438
1.33
0.61
5.6
4.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
86
0.56
0.60
4.0
3.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
8
54
1.53
0.59
6.3
2.5
g/l
10.4
9.2
—
8
44
(4094501)
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
9
59
1.59
0.57
11.9
4.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
60
1.56
0.56
7.1
3.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
61
554
1.34
0.55
34.7
16.5
%
36.0
40.6
1.83
40
360
(3028026) IgM [Mass/volume] in Serum or Plasma
7
45
1.60
0.50
1.9
1.8
g/l
1.3
1.2
—
7
37
(3011397) Hemoglobin [Presence] in Urine by Test strip
20
157
1.36
0.49
4.7
4.0
—
—
—
0
0
(3013512) EKG study
17
215
0.74
0.46
6.9
4.6
—
—
—
0
0
(3020891) Body temperature
5
33
1.55
0.42
6.0
4.0
—
—
—
0
0
(3044889) 12 lead EKG panel
51
462
1.25
0.42
5.2
4.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
16
0.00
0.41
0.0
1.5
—
1.7
—
0
11
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
35
304
1.25
0.41
4.7
4.5
ng/l
21.0
49.1
1.80
27
242
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
32
276
1.25
0.40
3.8
4.3
%
13.3
22.0
3.83
12
139
(40761535) Cells panel - Urine sediment
9
67
1.38
0.39
4.7
3.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
72
683
1.31
0.37
26.9
15.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
45
407
1.22
0.35
5.0
3.0
u/l
79.9
57.6
0.78
45
379
(3004588) Protein electrophoresis panel - Serum or Plasma
7
52
1.38
0.32
5.9
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
23
267
0.81
0.32
4.6
4.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
65
1.25
0.28
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
201
1.20
0.24
1.7
2.8
ug/l
0.5
0.8
1.26
14
135
(3030981) Hyaline casts [#/volume] in Urine by Automated count
5
39
1.30
0.23
2.0
3.2
e6/l
0.3
0.1
—
5
39
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
42
1.20
0.22
1.4
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.2
—
18.3
—
0
12
(3001019) Free T4 and TSH panel - Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
3.0
—
0
5
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
72
696
1.20
0.20
37.6
19.3
umol/l
84.8
83.8
0.11
72
696
(40760892) CBC W Ordered Manual Differential panel - Blood
13
150
0.84
0.16
6.4
5.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
9
82
1.11
0.15
3.3
4.5
ug/l
5.5
137.7
—
9
71
(3000492) Spirometry study
5
46
1.09
0.10
1.0
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
75
1.07
0.07
3.5
1.9
—
—
—
0
0
(3015736) pH of Urine
25
262
0.94
0.05
4.7
3.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
62
611
1.05
0.03
29.0
16.1
ml/min/173m2
72.2
76.2
0.74
56
492
(40768797) Stomach Pathology biopsy report
10
94
1.07
0.01
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
70
698
1.01
0.00
17.8
10.4
u/l
28.8
25.2
0.69
70
670
(3002385) Erythrocyte distribution width [Ratio]
54
538
1.01
0.00
37.8
19.8
%
14.2
14.0
0.40
54
524
(4027681)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
9
0.00
0.00
0.0
1.2
—
349.3
—
0
9
(4306422)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.2
—
103.7
—
0
9
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4268621)
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
1.9
—
0
5
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
17.7
—
0
6
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
11.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
7
0.00
0.00
0.0
1.1
—
33.7
—
0
7
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
262.6
—
0
7
(3051611) Lipemic interference index of Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
96.2
—
0
6
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
17.7
—
0
6
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_LIPORALPHARYNX – Carcinoma in situ of lip, oral cavity and pharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).